chloroquine has been researched along with Vasculitis in 12 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Vasculitis: Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vasculitis is a well recognised complication of Cystic Fibrosis." | 5.36 | Treatment of cystic fibrosis associated cutaneous vasculitis with chloroquine. ( Molyneux, ID; Moon, T; Morice, AH; Webb, AK, 2010) |
| "The pandemic outbreak of coronavirus disease 2019 (COVID-19) is rapidly spreading all over the world." | 2.66 | The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. ( Li, T; Liu, Z; Qin, Y; Wang, J; Wang, Q; Yan, X; Zeng, X; Zhang, F; Zhang, S; Zhang, W; Zhang, X; Zhao, Y, 2020) |
| "A 36-year-old woman with systemic lupus erythematosus was admitted to our hospital with malaise, myalgia, dysphagia, fever, preserved muscle strength, leukocytosis (15,600 cells), and increased creatine kinase of 1,358 IU/L that reached 75,000 IU/L in few days." | 1.37 | Fatal rhabdomyolysis in systemic lupus erythematosus. ( Bonfa, E; da Mota, LM; de Carvalho, JF, 2011) |
| "Vasculitis is a well recognised complication of Cystic Fibrosis." | 1.36 | Treatment of cystic fibrosis associated cutaneous vasculitis with chloroquine. ( Molyneux, ID; Moon, T; Morice, AH; Webb, AK, 2010) |
| " Over a 2-yr period we have prospectively reviewed 114 patients with a suspected adverse cutaneous reaction to anti-rheumatic drugs." | 1.29 | Suspected cutaneous drug toxicity in rheumatoid arthritis--an evaluation. ( Davis, MJ; Dawes, PT; Mattey, DL; Smith, AG; Wilkinson, SM, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, W | 1 |
| Zhao, Y | 1 |
| Zhang, F | 1 |
| Wang, Q | 1 |
| Li, T | 1 |
| Liu, Z | 1 |
| Wang, J | 1 |
| Qin, Y | 1 |
| Zhang, X | 1 |
| Yan, X | 1 |
| Zeng, X | 1 |
| Zhang, S | 1 |
| Murray, K | 1 |
| Quinn, S | 1 |
| Turk, M | 1 |
| O'Rourke, A | 1 |
| Molloy, E | 1 |
| O'Neill, L | 1 |
| Mongey, AB | 1 |
| Fearon, U | 1 |
| Veale, DJ | 1 |
| Molyneux, ID | 1 |
| Moon, T | 1 |
| Webb, AK | 1 |
| Morice, AH | 1 |
| de Carvalho, JF | 1 |
| da Mota, LM | 1 |
| Bonfa, E | 1 |
| Alekhin, DI | 1 |
| Fokin, AA | 1 |
| Mikhaĭlova, OA | 1 |
| Sumnaia, DB | 1 |
| Goloshchapova, ZhA | 1 |
| Roberts, JA | 1 |
| Hunter, JA | 1 |
| Wilkinson, SM | 1 |
| Smith, AG | 1 |
| Davis, MJ | 1 |
| Mattey, DL | 1 |
| Dawes, PT | 1 |
| Berlit, P | 1 |
| Härle, M | 1 |
| Buss, J | 1 |
| Klötzsch, C | 1 |
| Martínez-Rueda, JO | 1 |
| Arce-Salinas, CA | 1 |
| Kraus, A | 1 |
| Alcocer-Varela, J | 1 |
| Alarcón-Segovia, D | 1 |
| Chen, W | 1 |
| Thoburn, CJ | 1 |
| Miura, Y | 1 |
| Sommer, M | 1 |
| Hruban, R | 1 |
| Qian, Z | 1 |
| Baldwin, W | 1 |
| Hess, AD | 1 |
| Kalha, E | 1 |
| Van Vooren, JP | 1 |
| De Dobbeleer, G | 1 |
| Capel, P | 1 |
| Dugowson, CE | 1 |
| Gilliland, BC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Nutritional Habits, Does it Affect Coronavirus Disease 2019 (COVID-19) Infection Outcome? An Egyptian Experience[NCT04447144] | 200 participants (Anticipated) | Observational | 2020-06-01 | Recruiting | |||
| Evaluation of Independent Clinical- Laboratory Predictors of Clinical Outcomes in Hospitalized Positive SARS-CoV2 Patients (Outcomes SARS-CoV2)[NCT05162534] | 1,800 participants (Actual) | Observational | 2020-05-29 | Completed | |||
| Comparison of Cytokine Hemadsorption as an Immunomodulator Therapy in Covid 19 Patients With and Without Bacterial Sepsis[NCT04920851] | 23 participants (Anticipated) | Observational | 2021-06-10 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for chloroquine and Vasculitis
| Article | Year |
|---|---|
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir | 2020 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir | 2020 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir | 2020 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir | 2020 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir | 2020 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir | 2020 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir | 2020 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir | 2020 |
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Betacoronavirus; Chloroquine; Coronavir | 2020 |
Management of rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Azathioprine; Chloroquine; Cyc | 1986 |
10 other studies available for chloroquine and Vasculitis
| Article | Year |
|---|---|
COVID-19 and rheumatic musculoskeletal disease patients: infection rates, attitudes and medication adherence in an Irish population.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Attitude to Health; Biological Products; Chloroq | 2021 |
Treatment of cystic fibrosis associated cutaneous vasculitis with chloroquine.
Topics: Adult; Antirheumatic Agents; Chloroquine; Cystic Fibrosis; Exanthema; Humans; Male; Skin; Vasculitis | 2010 |
Fatal rhabdomyolysis in systemic lupus erythematosus.
Topics: Acute Kidney Injury; Adult; Anti-Bacterial Agents; Antibodies, Antinuclear; Arthritis; Azathioprine; | 2011 |
[Administration of prostaglandins Ei and immunotherapy in management of various-genesis trophic ulcers].
Topics: Administration, Oral; Alprostadil; Anti-Inflammatory Agents, Non-Steroidal; Chloroquine; Chronic Dis | 2007 |
Loch Fyne fever--a new diagnosis?
Topics: Chloroquine; Fever of Unknown Origin; Humans; Male; Middle Aged; Vasculitis | 1983 |
Suspected cutaneous drug toxicity in rheumatoid arthritis--an evaluation.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, | 1993 |
Rhabdomyolysis in vasculitis.
Topics: Adult; Chloroquine; Connective Tissue Diseases; Fatal Outcome; Female; Humans; Prednisolone; Rhabdom | 1993 |
Factors associated with fetal losses in severe systemic lupus erythematosus.
Topics: Adult; Analysis of Variance; Azathioprine; Case-Control Studies; Chloroquine; Cohort Studies; Congen | 1996 |
Autoimmune-mediated vasculopathy.
Topics: Adoptive Transfer; Animals; Antigens, Differentiation, B-Lymphocyte; Arteriosclerosis; Autoimmune Di | 2001 |
[Recurrent cutaneous ecchymoses and hypersensitivity to leukocytic stroma].
Topics: Adolescent; Autoantibodies; Chloroquine; Female; Humans; Leukocytes; Purpura; Vasculitis | 1992 |